PE20020583A1 - Derivados de benzodiazepina como moduladores del receptor gaba a - Google Patents

Derivados de benzodiazepina como moduladores del receptor gaba a

Info

Publication number
PE20020583A1
PE20020583A1 PE2001001135A PE2001001135A PE20020583A1 PE 20020583 A1 PE20020583 A1 PE 20020583A1 PE 2001001135 A PE2001001135 A PE 2001001135A PE 2001001135 A PE2001001135 A PE 2001001135A PE 20020583 A1 PE20020583 A1 PE 20020583A1
Authority
PE
Peru
Prior art keywords
benzodiazepine
triazolo
imidazo
alkyl
oxadiazol
Prior art date
Application number
PE2001001135A
Other languages
English (en)
Spanish (es)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20020583A1 publication Critical patent/PE20020583A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2001001135A 2000-11-16 2001-11-14 Derivados de benzodiazepina como moduladores del receptor gaba a PE20020583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16

Publications (1)

Publication Number Publication Date
PE20020583A1 true PE20020583A1 (es) 2002-07-06

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001135A PE20020583A1 (es) 2000-11-16 2001-11-14 Derivados de benzodiazepina como moduladores del receptor gaba a

Country Status (40)

Country Link
US (1) US6743789B2 (enExample)
EP (1) EP1337535B1 (enExample)
JP (1) JP4088151B2 (enExample)
KR (1) KR100504300B1 (enExample)
CN (1) CN1191255C (enExample)
AR (1) AR031345A1 (enExample)
AT (1) ATE268776T1 (enExample)
AU (2) AU2002217007B2 (enExample)
BG (1) BG107817A (enExample)
BR (1) BR0115393A (enExample)
CA (1) CA2427576C (enExample)
CZ (1) CZ295256B6 (enExample)
DE (1) DE60103776T2 (enExample)
DK (1) DK1337535T3 (enExample)
EC (1) ECSP034607A (enExample)
ES (1) ES2220831T3 (enExample)
GC (1) GC0000375A (enExample)
GT (1) GT200100230A (enExample)
HR (1) HRP20030360A2 (enExample)
HU (1) HUP0303281A3 (enExample)
IL (1) IL155813A0 (enExample)
JO (1) JO2359B1 (enExample)
MA (1) MA26962A1 (enExample)
MX (1) MXPA03004251A (enExample)
MY (1) MY141675A (enExample)
NO (1) NO324706B1 (enExample)
NZ (1) NZ525413A (enExample)
PA (1) PA8532401A1 (enExample)
PE (1) PE20020583A1 (enExample)
PL (1) PL362925A1 (enExample)
PT (1) PT1337535E (enExample)
RU (1) RU2278865C2 (enExample)
SI (1) SI1337535T1 (enExample)
SK (1) SK7232003A3 (enExample)
TR (1) TR200402073T4 (enExample)
TW (1) TWI239333B (enExample)
UY (1) UY27026A1 (enExample)
WO (1) WO2002040487A2 (enExample)
YU (1) YU35603A (enExample)
ZA (1) ZA200303435B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
AU2005272627A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
AU2005293820B2 (en) 2004-10-12 2010-11-25 F. Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
CA2584259C (en) * 2004-10-20 2013-04-02 F. Hoffmann-La Roche Ag Imidazo-benzodiazepine derivatives
EP1828194B1 (en) 2004-12-14 2008-05-28 F. Hoffmann-Roche AG Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
BRPI0617204A2 (pt) * 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2009139916A1 (en) * 2008-05-16 2009-11-19 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate hsp90 activity
CA2739900C (en) 2008-11-18 2016-11-08 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
SI2370441T1 (sl) * 2008-11-28 2013-12-31 F. Hoffmann-La Roche Ag Arilcikloheksiletri dihidrotetraazabenzoazulenov za uporabo kot antagonisti receptorja vazopresina V1A
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
CA2818025A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP2897963A4 (en) * 2012-09-21 2016-03-30 Uwm Res Foundation Inc Novel GABAA AGONISTS AND METHOD FOR USE TO COMBAT AIRWAY HYPER REAGIBILITY AND IGNITIONS IN ASTHMA
EP4032889A1 (en) * 2013-12-20 2022-07-27 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA2990004C (en) 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio, Inc. derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
AU2019288382B2 (en) * 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
AU2023324882A1 (en) 2022-08-19 2025-03-20 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (enExample) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
WO2002040487A3 (en) 2002-09-26
ES2220831T3 (es) 2004-12-16
ATE268776T1 (de) 2004-06-15
AU2002217007B2 (en) 2006-11-30
IL155813A0 (en) 2003-12-23
KR100504300B1 (ko) 2005-07-28
RU2003116895A (ru) 2005-02-20
ZA200303435B (en) 2004-08-05
GC0000375A (en) 2007-03-31
AU1700702A (en) 2002-05-27
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
NO20032208D0 (no) 2003-05-15
MXPA03004251A (es) 2003-09-22
DE60103776T2 (de) 2005-07-14
PA8532401A1 (es) 2002-08-26
BR0115393A (pt) 2004-07-06
KR20030045192A (ko) 2003-06-09
EP1337535B1 (en) 2004-06-09
CN1474820A (zh) 2004-02-11
DK1337535T3 (da) 2004-10-25
SI1337535T1 (en) 2004-10-31
MY141675A (en) 2010-06-15
BG107817A (bg) 2004-07-30
GT200100230A (es) 2002-07-04
ECSP034607A (es) 2003-06-25
HUP0303281A2 (hu) 2004-01-28
HK1062442A1 (en) 2004-11-05
RU2278865C2 (ru) 2006-06-27
JO2359B1 (en) 2006-12-12
NO20032208L (no) 2003-05-15
PL362925A1 (en) 2004-11-02
YU35603A (sh) 2006-05-25
CZ20031597A3 (cs) 2003-11-12
CA2427576A1 (en) 2002-05-23
PT1337535E (pt) 2004-09-30
CA2427576C (en) 2007-11-06
CN1191255C (zh) 2005-03-02
DE60103776D1 (de) 2004-07-15
HUP0303281A3 (en) 2005-05-30
AR031345A1 (es) 2003-09-17
NO324706B1 (no) 2007-12-03
MA26962A1 (fr) 2004-12-20
JP4088151B2 (ja) 2008-05-21
CZ295256B6 (cs) 2005-06-15
US20020103371A1 (en) 2002-08-01
SK7232003A3 (en) 2004-03-02
US6743789B2 (en) 2004-06-01
UY27026A1 (es) 2002-06-20
HRP20030360A2 (en) 2005-04-30
TWI239333B (en) 2005-09-11
WO2002040487A2 (en) 2002-05-23
JP2004517070A (ja) 2004-06-10
EP1337535A2 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
PE20020583A1 (es) Derivados de benzodiazepina como moduladores del receptor gaba a
ES2377849T3 (es) Compuestos amino-heterocíclicos
JP2020515603A (ja) Hpk1阻害剤としてのイソキノリン
AU2015251207B2 (en) Novel bicyclic or tricyclic heterocyclic compound
ES2924371T3 (es) Compuestos tricíclicos y su uso como inhibidores de la fosfodiesterasa
TW201041893A (en) Modulators of 5-HT receptors and methods of use thereof
EP3152214A1 (en) Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators
CA2844310A1 (en) Inhibitors of the renal outer medullary potassium channel
JP2004505085A (ja) ピペラジン誘導体
JP2012502067A (ja) 疾患の治療のためのヒスタミン受容体の複素環阻害剤
PE20060486A1 (es) Derivados de pirrol-oxindol como moduladores del receptor de progesterona
JP2004091490A (ja) 勃起機能不全の治療のためのcGMP−PDE阻害薬
DE69830503D1 (de) Tablette mit verlängerter wirkstoffabgabe zur behandlung der parkinsonkrankheit
CN102812005A (zh) β-分泌酶抑制剂
CN104245702B (zh) 新型神经激肽1受体拮抗剂化合物
MXPA03010529A (es) Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a.
KR101770979B1 (ko) 5­ht 수용체의 조절제 및 이의 사용방법
KR20250130621A (ko) 치환된 디하이드로피롤로[3,4-d]피리미딘 화합물 및 의학적 병태 치료에서의 이의 용도
JP2017504628A (ja) 縮合イミダゾール化合物
TW201100434A (en) Modulators of 5-HT receptors and methods of use thereof
CN117120419A (zh) Klk5双环杂芳香族抑制剂
TW200630372A (en) Imidazo-benzodiazepine derivatives
EP4634183A1 (en) Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditions
ATE402707T1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen
RU2393161C2 (ru) Тетрациклические имидазо-бензодиазепины в качестве модуляторов гамк-рецепторов

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed